In this study, we found that GRd protects against aging‐ and cancer‐induced skeletal muscle wasting by binding to STAT3, enhancing muscle function, and suppressing the expression of protein degradation factors such as MSTN, atrogin‐1, and MuRF‐1. Here, FBXO32 is linked to cancer.